X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2221) 2221
male (1496) 1496
female (1423) 1423
risk factors (1158) 1158
middle aged (1055) 1055
dyslipidemia (1004) 1004
adult (833) 833
dyslipidemias - physiopathology (760) 760
aged (714) 714
obesity (546) 546
hypertension (536) 536
insulin resistance (522) 522
animals (491) 491
metabolic syndrome (477) 477
dyslipidemias - blood (475) 475
dyslipidemias - complications (443) 443
dyslipidemias - epidemiology (439) 439
prevalence (432) 432
hypertension - physiopathology (429) 429
endocrinology & metabolism (402) 402
body mass index (395) 395
blood pressure (394) 394
cholesterol (379) 379
insulin-resistance (372) 372
diabetes (368) 368
dyslipidemias - drug therapy (364) 364
obesity - physiopathology (361) 361
lipids - blood (350) 350
atherosclerosis (336) 336
cardiac & cardiovascular systems (335) 335
biomarkers - blood (334) 334
metabolic syndrome - physiopathology (332) 332
cross-sectional studies (302) 302
cardiovascular-disease (295) 295
peripheral vascular disease (292) 292
cardiovascular diseases (278) 278
cardiovascular disease (277) 277
risk (277) 277
lipids (275) 275
hypertension - epidemiology (270) 270
cardiovascular diseases - physiopathology (269) 269
adolescent (260) 260
cardiovascular diseases - etiology (256) 256
triglycerides - blood (252) 252
risk-factors (251) 251
dyslipidemias - etiology (250) 250
diabetes mellitus (247) 247
diabetes mellitus, type 2 - physiopathology (245) 245
research (241) 241
coronary-heart-disease (233) 233
mortality (231) 231
inflammation (229) 229
treatment outcome (227) 227
young adult (223) 223
disease (220) 220
oxidative stress (220) 220
time factors (220) 220
cholesterol, ldl - blood (216) 216
cholesterol, hdl - blood (210) 210
hypertension - complications (209) 209
risk assessment (205) 205
obesity - complications (203) 203
cardiovascular diseases - epidemiology (201) 201
dyslipidemias - metabolism (200) 200
blood-pressure (197) 197
nutrition & dietetics (196) 196
blood glucose - metabolism (195) 195
cardiovascular diseases - prevention & control (188) 188
prospective studies (185) 185
analysis (183) 183
type 2 diabetes (183) 183
glucose (181) 181
pharmacology & pharmacy (180) 180
child (179) 179
health aspects (177) 177
aged, 80 and over (176) 176
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (175) 175
dyslipidemias - diagnosis (174) 174
metabolism (174) 174
insulin (171) 171
metabolic syndrome - epidemiology (170) 170
cholesterol - blood (168) 168
case-control studies (167) 167
association (166) 166
comorbidity (166) 166
triglycerides (165) 165
hypolipidemic agents - therapeutic use (161) 161
mice (159) 159
obesity - epidemiology (159) 159
lipoproteins (156) 156
care and treatment (153) 153
diabetes mellitus, type 2 - complications (153) 153
rats (150) 150
physiological aspects (149) 149
dyslipidemias (148) 148
endothelium, vascular - physiopathology (148) 148
age factors (144) 144
c-reactive protein (143) 143
retrospective studies (142) 142
medicine, general & internal (141) 141
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2388) 2388
Russian (43) 43
Spanish (33) 33
Portuguese (29) 29
Japanese (19) 19
French (18) 18
Chinese (13) 13
Czech (6) 6
German (6) 6
Hungarian (5) 5
Polish (5) 5
Croatian (4) 4
Italian (3) 3
Romanian (3) 3
Ukrainian (3) 3
Norwegian (2) 2
Dutch (1) 1
Finnish (1) 1
Icelandic (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental and Clinical Endocrinology & Diabetes, ISSN 0947-7349, 06/2009, Volume 117, Issue 6, pp. 241 - 250
Abstract The incidence of obesity has increased dramatically during recent decades. Obesity will cause a decline in life expectancy for the first time in... 
Review | Visceral fat | Adipocyte | Adipose tissue dysfunction | Obesity | Insulin resistance | Inflammation | Adipokines | MACROPHAGE INFILTRATION | adipose tissue dysfunction | RIBONUCLEIC-ACID EXPRESSION | WEIGHT-LOSS | EARLY-ONSET OBESITY | inflammation | GLUCOSE-METABOLISM | INSULIN-RESISTANCE | adipocyte | ENDOCRINOLOGY & METABOLISM | GENE-EXPRESSION | BODY-MASS INDEX | adipokines | visceral fat | insulin resistance | TYPE-2 DIABETES-MELLITUS | obesity | MECHANISMS LINKING OBESITY | Neoplasms - etiology | Fatty Liver - pathology | Atherosclerosis - genetics | Humans | Dementia - physiopathology | Dyslipidemias - pathology | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Adipose Tissue - metabolism | Adipokines - genetics | Diabetes Mellitus, Type 2 - etiology | Hypertension - genetics | Dyslipidemias - etiology | Atherosclerosis - pathology | Dementia - pathology | Atherosclerosis - physiopathology | Obesity - complications | Adipose Tissue - pathology | Lipid Metabolism | Obesity - physiopathology | Adipokines - metabolism | Hypertension - pathology | Obesity - pathology | Models, Biological | Insulin Resistance - genetics | Lung Diseases - physiopathology | Diabetes Mellitus, Type 2 - pathology | Cell Hypoxia - genetics | Fatty Liver - epidemiology | Lung Diseases - epidemiology | Neoplasms - epidemiology | Fatty Liver - etiology | Dyslipidemias - genetics | Diabetes Mellitus, Type 2 - genetics | Adipose Tissue - physiopathology | Dementia - epidemiology | Dementia - genetics | Atherosclerosis - epidemiology | Obesity - genetics | Lung Diseases - etiology | Hypertension - etiology | Atherosclerosis - etiology | Neoplasms - genetics | Hypertension - epidemiology | Neoplasms - physiopathology | Fatty Liver - genetics | Fatty Liver - physiopathology | Adipocytes - pathology | Hypertension - physiopathology | Obesity - metabolism | Dementia - etiology | Lung Diseases - genetics | Diabetes Mellitus, Type 2 - physiopathology | Dyslipidemias - epidemiology | Adipocytes - metabolism | Obesity - epidemiology | Lung Diseases - pathology | Neoplasms - pathology | Dyslipidemias - physiopathology
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2011, Volume 108, Issue 3, pp. 3B - 24B
Journal Article
Circulation research, ISSN 0009-7330, 03/2015, Volume 116, Issue 6, pp. 991 - 1006
Excess weight gain, especially when associated with increased visceral adiposity, is a major cause of hypertension, accounting for 65% to 75% of the risk for... 
blood pressure | kidney | chronic renal insufficiency | melanocortins | leptin | mineralocorticoids | CARDIAC & CARDIOVASCULAR SYSTEMS | SYMPATHETIC-NERVOUS-SYSTEM | NATRIURETIC PEPTIDES | CARDIOVASCULAR FUNCTIONS | BLOOD-PRESSURE | MELANOCORTIN SYSTEM | BODY-MASS-INDEX | RENIN-ANGIOTENSIN SYSTEM | ARTERIAL-PRESSURE | SELECTIVE LEPTIN RESISTANCE | PERIPHERAL VASCULAR DISEASE | CHRONIC KIDNEY-DISEASE | HEMATOLOGY | Natriuresis - physiology | Antihypertensive Agents - pharmacology | Intra-Abdominal Fat - physiopathology | Prevalence | Dyslipidemias - complications | Humans | Sodium - metabolism | Sympathetic Nervous System - physiopathology | Pro-Opiomelanocortin - physiology | Hypertension - etiology | Leptin - physiology | Insulin Resistance - physiology | Metabolic Syndrome - physiopathology | Models, Animal | Parasympathetic Nervous System - physiopathology | Hypertension - epidemiology | Kidney - physiopathology | Models, Cardiovascular | Obesity - complications | Aldosterone - physiology | Obesity - physiopathology | Renin-Angiotensin System - physiology | Antihypertensive Agents - therapeutic use | Organ Specificity | Pressure | Renal Insufficiency, Chronic - physiopathology | Hypertension - physiopathology | Metabolic Syndrome - complications | Animals | Heart Conduction System - physiopathology | Receptors, Leptin - physiology | Obesity - epidemiology | Renin-Angiotensin System - drug effects | Hemodynamics | Dyslipidemias - physiopathology | chronic kidney disease | sympathetic activity | Blood pressure | renin-angiotensin system
Journal Article
Journal Article
Journal of vascular surgery, ISSN 0741-5214, 2011, Volume 54, Issue 3, pp. 819 - 831
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2013, Volume 38, Issue 2, pp. 209 - 218
Summary Background Dyslipidemia and obesity have been observed in persons with severe anxiety or depression, and in tricyclic antidepressant (TCA) users. This... 
Endocrinology & Metabolism | Psychiatry | Autonomic nervous system | Tricyclic antidepressants | Depression | Lifestyle | Anxiety | HPA axis | Inflammation | C-REACTIVE PROTEIN | METABOLIC SYNDROME | SLEEP DURATION | RATE-VARIABILITY | PSYCHIATRY | SALIVARY CORTISOL | FOLLOW-UP | MAJOR DEPRESSION | ADRENAL AXIS | NEUROSCIENCES | ENDOCRINOLOGY & METABOLISM | ANTIDEPRESSANT USE | CORONARY-HEART-DISEASE | Psychiatric Status Rating Scales - statistics & numerical data | Depression - physiopathology | Life Style | Dyslipidemias - complications | Obesity - psychology | Humans | Middle Aged | Male | Autonomic Nervous System - physiopathology | Depression - metabolism | Dyslipidemias - psychology | C-Reactive Protein - metabolism | Anxiety - complications | Adult | Depression - complications | Female | Anxiety - metabolism | Hypothalamo-Hypophyseal System - physiopathology | Pituitary-Adrenal System - physiopathology | Obesity - complications | Pituitary-Adrenal System - metabolism | Risk Factors | Anxiety - psychology | Anxiety - physiopathology | Obesity - physiopathology | Hypothalamo-Hypophyseal System - metabolism | Obesity - metabolism | Antidepressive Agents, Tricyclic - therapeutic use | Adolescent | Depression - psychology | Dyslipidemias - metabolism | Aged | Lipid Metabolism - physiology | Dyslipidemias - physiopathology | Inflammation - physiopathology | Psychological aspects | Obesity | Depression, Mental | Antidepressants, Tricyclic
Journal Article
Atherosclerosis, ISSN 0021-9150, 2015, Volume 239, Issue 2, pp. 483 - 495
Abstract Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for patients with type 2 diabetes, despite recent significant... 
Cardiovascular | Type 2 diabetes | CVD | Fatty liver | Dyslipidemia | β-oxidation | Triglycerides | De novo lipogenesis (DNL) | CARDIAC & CARDIOVASCULAR SYSTEMS | DE-NOVO LIPOGENESIS | FATTY LIVER-DISEASE | B-CONTAINING LIPOPROTEINS | LOW-DENSITY-LIPOPROTEIN | TRIGLYCERIDE-RICH LIPOPROTEINS | STEAROYL-COA DESATURASE | beta-oxidation | HEPATIC INSULIN-RESISTANCE | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | GROWTH-FACTOR 21 | APOLIPOPROTEIN-C-III | Prevalence | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Intestines - metabolism | Liver - physiopathology | Diabetes Mellitus, Type 2 - epidemiology | Dyslipidemias - blood | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Dyslipidemias - diagnosis | Cardiovascular Diseases - physiopathology | Dyslipidemias - drug therapy | Risk Assessment | Liver - metabolism | Risk Factors | Biomarkers - blood | Lipoproteins - blood | Diabetes Mellitus, Type 2 - diagnosis | Diabetes Mellitus, Type 2 - blood | Animals | Diabetes Mellitus, Type 2 - physiopathology | Dyslipidemias - epidemiology | Lipid Metabolism - drug effects | Triglycerides - blood | Hypolipidemic Agents - therapeutic use | Intestines - physiopathology | Blood Glucose - metabolism | Dyslipidemias - physiopathology | Blood lipids | Low density lipoproteins | Mortality | HEPATIC | ISCHEMIC-HEART-DISEASE | Peripheral Vascular Disease | Kardiologi | Cardiac and Cardiovascular Systems | NONALCOHOLIC FATTY LIVER | INSULIN-RESISTANCE | CORONARY-ARTERY-DISEASE
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2015, Volume 116, Issue 6, pp. 838 - 844
Myocardial Infarction with normal coronary arteries (MINCA) is common with a prevalence of 1% to 12% of all myocardial infarctions. The pathogenic mechanisms... 
Cardiovascular | CARDIAC & CARDIOVASCULAR SYSTEMS | STRESS | PROGNOSIS | APICAL BALLOONING SYNDROME | ENDOTHELIAL FUNCTION | CARDIOMYOPATHY | Carotid Artery, Common - diagnostic imaging | Myocardial Infarction - epidemiology | Humans | Middle Aged | Coronary Disease - physiopathology | Male | Case-Control Studies | Takotsubo Cardiomyopathy - complications | Dyslipidemias - blood | C-Reactive Protein - metabolism | Coronary Disease - complications | Cholesterol, LDL - blood | Female | Myocardial Infarction - physiopathology | Hypertension - epidemiology | Vasodilation - physiology | Myocardial Infarction - etiology | Mental Disorders - epidemiology | Carotid Intima-Media Thickness | Risk Factors | Endothelium, Vascular - physiopathology | Inflammation | Takotsubo Cardiomyopathy - epidemiology | Coronary Angiography | Dyslipidemias - epidemiology | Takotsubo Cardiomyopathy - physiopathology | Coronary Disease - diagnostic imaging | Sex Factors | Triglycerides - blood | Biomarkers | Cholesterol, HDL - blood | Aged | Plethysmography | Hypertension | Low density lipoproteins | Cardiac patients | Atherosclerosis | Glucose | Mental illness | Risk factors | Heart attack | Arteries | Dextrose | Prevalence studies (Epidemiology) | Medical records | Cardiovascular disease | Heart attacks | Cholesterol | Carotid Artery | HDL/blood | Kardiologi | Coronary Disease/complications/diagnostic imaging/physiopathology | Vascular/physiopathology | Vasodilation/physiology | Common/diagnostic imaging | Hypertension/epidemiology | Dyslipidemias/blood/epidemiology | Endothelium | Cardiac and Cardiovascular Systems | Takotsubo Cardiomyopathy/complications/epidemiology/physiopathology | Mental Disorders/epidemiology | Triglycerides/blood | LDL/blood | C-Reactive Protein/metabolism | Myocardial Infarction/epidemiology/etiology/physiopathology
Journal Article